National Healthcare Properties Q2 2026 Earnings Report

National Healthcare Properties EPS Results

• Actual EPS: -$0.13
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: -$0.85

National Healthcare Properties Revenue Results

• Actual Revenue: $87.53 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

National Healthcare Properties Announcement Details

• Quarter: Q2 2026
• Date: 8/5/2026
• Time: After Market Closes
• Conference Call Date: Thursday, August 6, 2026
• Conference Call Time: 2:00PM ET

National Healthcare Properties (NASDAQ:NHP) Inc. is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing. National Healthcare Properties Inc. is based in NEW YORK.

National Healthcare Properties Q2 2026 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: SHOP same-store cash NOI increased 20.1% year over year, supported by higher occupancy, 5.9% RevPOR growth, and a 230-basis-point expansion in NOI margin to 22.4%. Management raised full-year SHOP same-store NOI growth guidance to 15%-18%.
• Positive Sentiment: NHP completed or contracted approximately $400 million of senior housing investments since the start of the second quarter, with 2026 year-to-date acquisitions totaling $280 million at a 7.9% year-one yield and projected 9.7% year-three yield.
• Positive Sentiment: The balance sheet strengthened materially after the IPO, with net debt to annualized further adjusted EBITDA falling to 4.6x from 8.6x. NHP also upsized its credit facility to $1.2 billion, repaid its only 2026 debt maturity, and plans to redeem its preferred stock.
• Positive Sentiment: The planned sale of 86 outpatient medical facilities for approximately $528 million has passed the buyer’s due diligence period and is progressing toward closing, potentially providing additional capital for senior-housing acquisitions and deleveraging.
• Negative Sentiment: Normalized FFO per share declined to $0.18 because the IPO materially increased the share count, while third-quarter SHOP results may face temporary pressure from occupancy-focused concessions and slower-than-expected occupancy gains at some communities.

Presentation

[Operator]

Hello, everyone. Thank you for joining us, and welcome to National Healthcare Properties' second quarter 2026 earnings conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Michael Ozuna, Director of Investor Relations. Mike, please go ahead.

[Michael Ozuna, Director of Investor Relations at National Healthcare Properties Inc]

Welcome to the second quarter 2026 webcast for National Healthcare Properties Inc. All participants will be in listen-only mode. Please note this event is being recorded. Also note that certain statements and assumptions in this webcast presentation, which are not historical facts, will be forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain assumptions and risk factors, which could cause the company's actual results to differ materially from the forward-looking statements. The company refers you to its SEC filings, including its most recent Form 10-K, for a detailed discussion of the risk factors that could cause these differences and impacts in its business. During today's call, the company will also discuss certain non-GAAP financial measures.

[Michael Ozuna, Director of Investor Relations at National Healthcare Properties Inc]

These measures should not be considered in isolation or as a substitution for the financial results prepared in accordance with GAAP. The company will provide a reconciliation of these measures to the most directly comparable GAAP measure as part of its second quarter 2026 earnings supplemental on its website at www.nhpreit.com. A question and answer session will follow the prepared remarks. Please note that a replay of the webcast will be available on the company's website later today. I would now like to turn the call over to the company's executive management team. Please go ahead, Michael.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thank you, Mike. Good afternoon, and welcome to National Healthcare Properties' second quarter 2026 earnings call. I am Michael Anderson, Chief Executive Officer of NHP. I'm joined today by Drew Babin, our Chief Financial Officer, who will speak to our financial results and outlook in greater detail following my remarks. Last quarter, our first earnings call as a publicly traded company, we laid out a straightforward agenda. Grow the SHOP portfolio through disciplined acquisitions with best-in-class operators, concentrate our capital in senior housing, build a balance sheet consistent with an investment-grade unsecured issuer. Second quarter was one of substantial execution against each of those objectives. Beginning with operations, our SHOP segment delivered same store cash NOI growth of 20.1% year-over-year, marking another quarter of double-digit growth driven by occupancy, rate, and margin.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Same store average occupancy reached 84.1%, same store cash NOI margin expanded 230 basis points to 22.4%. Importantly, the composition of that growth is maturing in a way we would expect, with both rate and operating leverage contributing to an increase in share as the portfolio approaches stabilization. Drew will walk through the detail. Our three operating partners, Senior Lifestyle, Discovery Senior Living, and AgeWell Senior Living, now collectively manage our 56 SHOP communities. Each continues to demonstrate the quality of resident care and operational discipline that underpin these results, and we're grateful for their partnership as we continue to scale alongside them. Turning to external growth, the second quarter and the period immediately following it represented the most active stretch of investment activity in the company's history.

[Michael Anderson, CEO at National Healthcare Properties Inc]

In late June, we acquired two senior housing communities in the Midwest totaling 211 units for a purchase price of $98 million, which are being managed by one of our trusted operating partners. In July, we closed on 17 communities comprising 1,003 units across the Midwest, South, Mid-Atlantic, and Pacific Northwest for approximately $182 million. 13 of these communities were acquired through the joint venture with Discovery Senior Living we announced last quarter, in which we hold an approximately 98.5% interest. As part of that transaction, we retain a right of first refusal and a purchase option on an additional 13 Discovery-managed communities, providing a defined pathway for continued growth with a partner that we know well. Taken together, our 2026 year-to-date acquisitions total 19 properties and 1,214 units for approximately $280 million at a blended year one yield of 7.9% and a projected year three yield of 9.7%.

[Michael Anderson, CEO at National Healthcare Properties Inc]

That spread between initial and stabilized yield is deliberate. We're underwriting assets where our operating partners and our asset management team can drive measurable improvement, and we're being paid to do that work. We also have a well-defined near-term pipeline. In late June, we entered into a definitive purchase and sale agreement to acquire three communities in Illinois with 178 units for $30 million. In July, we entered into a definitive agreement to acquire two communities in Florida with 200 units for $90 million. Each of these transactions is expected to close in the third quarter, subject to customary closing conditions and applicable regulatory approvals. In addition to the two previously referenced transactions, on August 4th, we were designated the stalking horse bidder for five SHOP communities through a bankruptcy proceeding.

[Michael Anderson, CEO at National Healthcare Properties Inc]

The acquisitions of these communities is subject to an auction process. However, given our stalking horse designation, should we not be successful in acquiring these communities, we will be entitled to a breakup fee and expense reimbursement collectively in excess of $4.8 million. It's important to highlight that a majority of the transaction will be funded with NHP OP units or REIT shares, further de-leveraging the balance sheet and adding SHOP communities in which we have strong conviction around near and long-term growth. On the capital recycling side, we continue to advance the strategic rotation we announced in May. Our agreement to divest a portfolio of 86 outpatient medical facilities for a disposition price of approximately $528 million is now hard. The buyer's due diligence period expired in mid-July. It is only subject to lender consent for the loan assumption and other customary closing conditions.

[Michael Anderson, CEO at National Healthcare Properties Inc]

We continue to explore strategic opportunities related to the remainder of our OMF portfolio as we focus on completing the reorientation into a full SHOP portfolio. We'll provide further updates as these processes advance. In May, we entered into a definitive purchase and sale agreement to sell one non-core SHOP community in California for approximately $42 million. That sale carries a 1.7% cap rate based on trailing 12-month results and further aligns the portfolio with our strategic focus on markets where we have the greatest opportunities for scale and growth. I would also note two items on governance that speak to the company's evolution. We announced the appointment of Al Campbell to our board of directors as an independent director, effective August 10th.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Al recently retired from his role as chief financial officer of Mid-America Apartment Communities, a role he held for 14 years through tremendous growth and performance at Mid-America. He brings decades of public company leadership and experience to our board, and we're very pleased to have him joining us. We've also begun another board process to identify a new independent director, further solidifying our commitment to continued enhancement of our company's governance. I'll now hand the call over to Drew Babin, our Chief Financial Officer.

[Drew Babin, CFO at National Healthcare Properties Inc]

Thank you, Michael. Second quarter normalized FFO was approximately $10.9 million, or $0.18 per share. On an absolute basis, NFFO increased year-over-year on higher NOI and interest income, as well as lower interest expense, net of higher G&A, primarily in the form of equity-based compensation. The increase in shares resulting from our highly deleveraging April IPO resulted, as expected, in sequential and year-over-year declines in NFFO per share. It's worth mentioning that normalized FFO for the second quarter of this year excludes the benefit of $1.2 million, or $0.02 per share, offset the interest expense resulting from derivatives mark-to-market and terminations. Within the SHOP segment, same-store cash net operating income increased 20.1% on a year-over-year basis, driven by an increase in average occupancy, a meaningful pickup in year-over-year RevPOR growth, and continued improvement in operating margins.

[Drew Babin, CFO at National Healthcare Properties Inc]

Same-store average occupancy reached 84.1% for the quarter, a 140 basis point improvement relative to the second quarter of 2025. As we noted last quarter, the accelerating rate of year-over-year growth in occupancy is not unexpected given the rapid occupancy growth our portfolio experienced in 2024 and in 2025 on the heels of game-changing operator transitions. We nevertheless expect continued growth in occupancy with accelerating tailwinds from improving rates and margins. While the SHOP segment performed ahead of our NOI growth expectations in the second quarter on rate and margin outperformance, resulting in an increase in our full-year same-store cash NOI growth guidance, I will further detail momentarily, occupancy growth contributed less than we anticipated. The lag was centered within the AL segment as we supported an operator's strategic decision to upgrade certain key property-level leadership roles, including at the executive director and sales leadership levels during the quarter.

[Drew Babin, CFO at National Healthcare Properties Inc]

We believe that this was the correct long-term decision in the interest of improving long-term NOI potential, and note that the same operator led occupancy gains across our portfolio in July and is still on track to produce NOI in line with their expectations heading into this year. Same-store RevPOR increased 5.9% year-over-year to $6,390 as new leasing activity provided a benefit to revenue beyond the roughly 5% average annual escalators that went into effect in January across nearly our entire portfolio. We're confident that our strategic focus on high acuity care and private pay residents, together with our willingness to invest capital in revenue-enhancing projects, position us to generate consistent mid-single-digit RevPOR growth far into the cycle.

[Drew Babin, CFO at National Healthcare Properties Inc]

Same-store cash NOI margin expanded 230 basis points year-over-year to 22.4%, a moderation in the growth of compensation-related expenses as the portfolio approaches fully staffed levels and as growth in other expenses remains relatively benign. Looking to our outpatient medical facilities, our OMF segment, same-store cash NOI decreased 0.4% year-over-year to $20.2 million, despite a 30 basis point sequential increase in occupancy and a 97% retention rate due to a one-time increase in utility and other non-reimbursable expenses during the quarter. Segment performance continues to track well within our same-store guidance range for this year. Before I move to full-year guidance, it is worth taking a moment to comment on the evolution of our balance sheet. Net debt to annualized further adjusted EBITDA declined sharply to 4.6x in the second quarter versus 8.6x in the first quarter as a result of our IPO.

[Drew Babin, CFO at National Healthcare Properties Inc]

As announced yesterday, we recast our credit facility, increasing the overall size from $550 million to $1.2 billion. It includes an incremental $150 million term loan, a new $150 million delayed draw term loan, and an increase of $350 million in the size of the revolver, all at improved spreads and term relative to our prior facility. We're appreciative of the banking group that understands not only our current portfolio and capital structure, but the overall strategic vision upon which we continue to execute. We used the facility to repay at par approximately $332 million of Fannie Mae loans, which represented our only debt maturity for this year. We expect to further utilize the revolving credit facility from time to time to fund acquisitions and the redemption of our Series A and Series B preferred stock to the extent they occur prior to the closing of announced OMF dispositions.

[Drew Babin, CFO at National Healthcare Properties Inc]

It remains our plan to achieve and maintain levels of financial leverage consistent with investment-grade unsecured issuers, particularly as our portfolio is increasingly oriented towards SHOP. We updated certain elements of our guidance to incorporate second quarter results as well as our expectations for the remainder of the year. We increased our SHOP same-store cash NOI growth guidance by 2% at both the low and high ends to 15%-18%, or approximately $51.6 million-$52.9 million. It is worth noting that third quarter same-store NOI growth is expected to be negatively impacted by short-term incentives targeting communities with occupancy levels generally remaining below 85%. These concessions, which reduce revenue only in the one or two months they generally occur, may delay the typical seasonal ramping of revenue we see in the third quarter into the early fall months.

[Drew Babin, CFO at National Healthcare Properties Inc]

We and our operators strongly believe that proactively increasing occupancy at these properties is the right strategy to accelerate their progress to the NOI levels we believe they can generate. As I mentioned before, RevPOR growth has outperformed our expectations year to date. Compensation-related expenses continue to moderate and, in addition, will begin to benefit from reduced property insurance premiums beginning in the third quarter. OMF same-store cash NOI growth guidance of 2.5%-3.5%, or $81.2 million-$82 million, is unchanged and does not account for expected OMF dispositions. Notably, steady revenue drivers, normalization of utility expenses, and savings on property insurance are expected to contribute positively to growth in the back half of the year.

[Drew Babin, CFO at National Healthcare Properties Inc]

While the speed of execution and pricing of our external growth has exceeded our prior expectations, we continue to expect $375 million-$425 million of acquisitions in 2026 based on our updated disposition guidance of $570 million and where we would like to see our balance sheet positioned at year-end. Given uncertainty related to the outcome of the auction for the five pipeline properties Michael mentioned earlier, we have chosen not to include these in our acquisition guidance range. Should we acquire the facilities, at least 1/2 of the total consideration will be funded with NHP OP units or REIT shares issued to the seller pursuant to the terms of the agreement.

[Drew Babin, CFO at National Healthcare Properties Inc]

We're increasing our total G&A and equity compensation guidance by $1 million each to $27 million-$28 million and $6 million-$7 million, respectively, due to an anticipated increase in non-cash equity compensation related to the ongoing refreshment of our board of directors. Our decision to proactively address maintenance capital expenditures across our portfolio in 2024 and 2025 in preparation for the IPO continues to result in a lower rate of recurring CapEx spend this year and a greater focus on revenue-enhancing projects at existing and acquisition properties. Our expectation for same-store recurring capital expenditures remains unchanged at $22 million-$25 million, as we do generally expect same-store spending to be weighted towards the back half of this year. We plan to update this range as announced portfolio transactions are consummated. Now I'll hand it back to Michael for closing remarks.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thanks, Drew. Second quarter was a quarter of execution, turning the strategy and the capital we raised in April into assets, into a materially stronger balance sheet, and into a clear path to the portfolio we intend to own. Our SHOP segment delivered another quarter of 20%+ same-store growth, and the drivers of that growth are broadening from occupancy recovery to rate and margin. Transactions team, led by Tyler Brawner, closed or placed under contract approximately $400 million of senior housing since the start of the second quarter at yields that we believe are highly accretive to our cost of capital. Our leverage now stands at 4.6x. Our only 2026 maturity has been retired. Credit facility has been recast and upsized to $1.2 billion at improved pricing, and we've announced the full redemption of our preferred stock.

[Michael Anderson, CEO at National Healthcare Properties Inc]

The announced OMF disposition, when completed, will provide additional balance sheet flexibility to accelerate our growth strategy in the senior housing-focused portfolio. We're executing on the plan we described to investors in April, and we're doing so ahead of the pace we previously discussed. Importantly, we remain disciplined in our approach with the right team and infrastructure in place to support our growth. We look forward to updating our shareholders on continued progress in the quarters ahead. With that, I'll turn the call back to the operator for the question and answer session.

[Operator]

We will now begin the question and answer session. Please limit yourself to one question and one follow-up. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of John Kilichowski with Wells Fargo. Your line is open. Please go ahead.

[John Kilichowski, Analyst at Wells Fargo]

Hi. Good afternoon. Thanks for taking my question. My first one, Drew, just the press that were taken out post quarter end. I know there's not an FFO guidance, so it doesn't necessarily impact that, but could you talk about how that impacts your guidance or sort of the pro forma leverage and balance sheet outlook for the rest of the year? Especially could you give us some color around maybe after the OMF sale and reaching the midpoint of guidance on the—

[Drew Babin, CFO at National Healthcare Properties Inc]

Sure.

[John Kilichowski, Analyst at Wells Fargo]

—on the acquisition side?

[Drew Babin, CFO at National Healthcare Properties Inc]

Yeah. Hi, John. Back in May, we put a slide in our deck that kind of laid out just based on the OMF disposition, the IPO, and credit facility pay down, as well as our acquisition guidance, kind of where leverage would end up for the end of the year. Including preferred, it was, call it low to mid-fives. Since then, we announced the non-core SHOP disposition. That probably helps that a little bit. Really with the preferred redemption, we're saving on costs. Obviously, the interest expense on our line of credit is lower than the preferred dividend rate. There'll be net savings. It really has the effect of just kind of converging our with and without preferred leverage ratios, kind of both to the low fives.

[Drew Babin, CFO at National Healthcare Properties Inc]

Which is a place where we would like to be kind of going into next year and potentially a further rotation towards SHOP.

[John Kilichowski, Analyst at Wells Fargo]

Okay. Thank you. The deal that you're talking about in the auction, it sounded like you were saying that sits outside of guidance currently. That would be, if that deal were to close, that would be above and beyond the $400 midpoint?

[Drew Babin, CFO at National Healthcare Properties Inc]

That's correct.

[John Kilichowski, Analyst at Wells Fargo]

Okay. Got it.

[Drew Babin, CFO at National Healthcare Properties Inc]

As we've said before, the restraint on our guidance, kind of stopping at $400 million or that range for acquisitions is really leverage, and wanting our leverage to be kind of in a comfortable range at year-end. As Michael mentioned in his remarks, the pipeline's very robust. We're hesitant to up our guidance until funding is spoken for. With this deal, the funding is already kind of baked into it if we do win the auction in the form of OP and REIT units.

[John Kilichowski, Analyst at Wells Fargo]

Mm-hmm. Very helpful. Thank you.

[Drew Babin, CFO at National Healthcare Properties Inc]

Thanks, John.

[Operator]

Your next question comes from the line of Ronald Kamdem with Morgan Stanley. Your line is open. Please go ahead.

[Ronald Kamdem, Analyst at Morgan Stanley]

Hey, great. Thanks so much for the time. Just starting with the same store NOI and the guide raise and so forth. I think talk through some operator transitions and so forth. Just curious as you're taking a step back, if you could just comment on what you think is sort of the upside, what's driving the upside, and what sort of further could go from here?

[Drew Babin, CFO at National Healthcare Properties Inc]

Hi, Ron. To get started, the second quarter outperformance relative to our guidance range is really the main reason why we increased it. As we said in the prepared remarks, in the second quarter, occupancy didn't come along as much as we thought it would. As we also mentioned in the third quarter, we're really targeting properties at lower levels of occupancy and selectively applying concessions there, really to try to get occupancy to a better place. We believe that's the right long-term decision for NOI. Subject to those things, we'll keep the guidance range updated. We have seen expenses, especially on the compensation side, continue to moderate, which helps as well. Obviously, we'll watch these things as the year goes on and update guidance as we go.

[Ronald Kamdem, Analyst at Morgan Stanley]

Great. If I could, my quick follow-up. I think interesting you were talking about sort of funding. Maybe can you just give us an update on the OMF sale? I know that the release had said 3Q or 4Q close, if any more visibility there. Beyond this sort of first tranche, just what's the thinking on the next tranche on OMF sales, the fund, this robust acquisition pipeline? Thanks.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Sure. Hey, Ron, it's Michael. As we mentioned, deal went hard in mid-July, and we expect that a portion of that will close in the third quarter. Another portion likely early fourth quarter, but I think too early to tell just given the loan assumption process around that. As we think about the remaining portion of the OMF portfolio, there's certainly been no shortage of interest and inbound on that portfolio. I think you see it across OMF transactions more broadly, speaking. As we think about monetizing that side of the portfolio, it's really thinking about that relative to the acquisition pipeline. As Drew mentioned, robust pipeline right now, so it's certainly front of mind for us.

[Ronald Kamdem, Analyst at Morgan Stanley]

Thank you.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thanks.

[Operator]

Your next question comes from the line of Julien Blouin with Goldman Sachs. Your line is open. Please go ahead.

[Julien Blouin, Analyst at Goldman Sachs]

Thank you for taking my question. I appreciate the color on the drag on occupancy at some of those properties where there's leadership turnover. Can you give us a sense of how we should think about occupancy growth over the back half of the year? It sounds like you've already seen some occupancy pick up at some of those affected properties so far in the third quarter. Am I understanding that right, that that improvement is not baked into your current guidance? Your current guidance update only reflects the second quarter outperformance?

[Drew Babin, CFO at National Healthcare Properties Inc]

Yeah, I'll get that started, Julien. I think you're right in that the guidance increase has more to do with the second quarter actual performance. I think with the moving parts contributing to same store NOI growth, obviously revenue can be driven in two different ways. I think as concessions are applied to the extent occupancy improves, certainly the third quarter, you may see it come out of RevPOR to some degree temporarily. Certainly the expense moderations continue. Again, as we monitor these different moving parts, we'll update guidance. To your point, the increase in guidance had a lot more to do with the second quarter. Again, we'll update it as we execute over the rest of the year.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah. Julien, just to add on that, as Drew mentioned in his remarks, those communities where we made some strategic changes in the second quarter, we saw the benefit of that starting in July. Those communities actually led the occupancy gains in July for us. I think as we've traditionally seen Q2, Q3 be the strongest seasons for leasing, I think we're expecting that Q3 and into Q4 will actually be strong for us given the impact of those executive leadership changes. As Drew mentioned, we're really focused on communities that have sub 85% occupancy. It's a limited number within the portfolio. On the other end of the spectrum, we've got communities within the portfolio that are highly occupied. Over the last several months, we've been dynamically changing street rates, with 3%-5% increases over in-place street rates mid-year.

[Michael Anderson, CEO at National Healthcare Properties Inc]

I think we're seeing a lot of strong demand across the board, and I think that the strategic changes made by the operators will certainly benefit us in the back half of the year.

[Julien Blouin, Analyst at Goldman Sachs]

Okay, great. That's helpful. I believe you recently tied down Tyler Brawner as EVP of Investments. Well, one, is that correct? How should we think about additional hires and sort of filling out that investments team from here as you hopefully start to approach the kind of cost of capital that could allow you to be even more active on the acquisition front?

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah, we did bring Tyler on full time. He is EVP of Investments, joined us in July. We're happy to have him on board, and certainly been a valuable member of the team even before joining us as a full-time employee. I think Tyler, together with some other individuals on the team that have been in kind of the medical healthcare space for decades, have a lot of strong relationships with brokers, with owner operators, with operating partners. We continue to see a lot of deal flow from our existing operators but also from the incoming operators. I think you should expect to see some additional operators in the mix beginning this month with a three-pack that we're closing in Illinois. We'll be bringing Priority Life as the operator on that deal, and similarly, they would be the operator on the five-pack that's subject to the auction.

[Michael Anderson, CEO at National Healthcare Properties Inc]

They've been a good source of flow since we've begun those conversations. Lindsay and the team have been in pretty deep conversations with a number of other operators that I think will ultimately be added to the roster.

[Julien Blouin, Analyst at Goldman Sachs]

Okay, great. Thank you so much, team.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thanks.

[Operator]

Your next question comes from the line of Juan Sanabria with BMO Capital Markets. Your line is open. Please go ahead.

[Robin Haneland, Analyst at BMO Capital Markets]

Hi, this is Robin Haneland sitting in for Juan. I was just curious on the potential acquisitions going through the auction. What's the expected yield here, and what's the status of the operations of the facilities, and where's occupancy at?

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah. Hey, Robin. It's Michael. This portfolio is sitting somewhere mid to high 80% occupancy. Really struggled over the last few years. I think with some new operators, they've turned it around, and I think there's a lot of upside still yet to be realized there. That's a kind of low to mid 7% year one and then kind of touching a 9% year three. We see a lot of quick growth in those. They also tend to be newer vintage communities. I think we're optimistic about the outcome. Certainly, put a lot of work and diligence into those five assets and think they would be a nice addition to the portfolio.

[Drew Babin, CFO at National Healthcare Properties Inc]

It's Drew here. I think it's safe to say that the yields, kind of in the first year but also year three, will not be materially different than the blended numbers that we've talked about and reported.

[Robin Haneland, Analyst at BMO Capital Markets]

Agreed. Got it. On Discovery ROFR, where do we stand on that? I was kind of curious what the later calls are.

[Michael Anderson, CEO at National Healthcare Properties Inc]

We continue to receive monthly financial updates from them on those 13 [properties]. Given the fixed purchase price and the option, that price per unit is very similar to the 13 [properties] that we closed on. It's a very attractive basis for us, but we'd like to see some continued improvement in the occupancy and margin from them.

[Robin Haneland, Analyst at BMO Capital Markets]

Thank you.

[Operator]

Your next question comes from the line of Michael Carroll with RBC Capital Markets. Your line is open. Please go ahead.

[Michael Carroll, Analyst at RBC Capital Markets]

Thanks. I wanted to circle back on the specific operator that has elected to make some leadership changes at the ED level and the sales level. I mean, how widespread were these changes? I know it sounds like it was pretty widespread since you're calling it out here as the reasoning that could have impacted the 2Q results. How many communities did it impact, and what's the reason for them electing to make this upgrade?

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah, I think it was six communities within the R1 portfolio. We've spoken pretty extensively about the tremendous growth that we saw once that operator transition took place. As we looked at the long-term growth potential in that portfolio with our operating partner there, I think we all came to the conclusion that there needed to be some new blood to really take performance to the next level. We started to see that pretty quickly. That portfolio led the way in occupancy gains in July for us. I think it was a good team to start with, but even better now and ultimately the right decision for us.

[Michael Carroll, Analyst at RBC Capital Markets]

I think you said earlier that you plan on adding new sales, like expanding the sales teams at those communities. Is that more at a community level or portfolio-wide level within Artem? I guess how should we think about that?

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah. That was part of the conversations that we had in Q2 with the operator. As a result, they've added some additional regional sales leadership actually hired a divisional sales leader, which is, as we think about kind of the most senior salesperson within that brand. Certainly, an enhancement to the community level leadership, but also some additional commitment from our operating partner around more senior personnel in that portfolio.

[Michael Carroll, Analyst at RBC Capital Markets]

Okay, great. Just if I can sneak one last one in. When did those transitions actually occur? I guess it sounds like it was an impact in 2Q, but given your comments on July, it's no longer an impact going forward and may be more of a benefit.

[Michael Anderson, CEO at National Healthcare Properties Inc]

I think those were mostly kind of mid-Q2 changes. We're starting to see the benefit of those, and certainly they were the leader in the clubhouse in our July results.

[Drew Babin, CFO at National Healthcare Properties Inc]

It's Drew here. I'll say, too, that in the third quarter, the properties that we're targeting with the concessions, it's not that same operator, or it's not just that same operator. It's kind of across the board, just looking at our portfolio and identifying properties where we can kind of raise the floor as far as where our portfolio as a whole sits and get those properties to a better place where rate can be driven a little better and the expenses flow through begins to improve. It's not necessarily the same situation. The third quarter is a bit of a separate effort than what we saw in the second quarter.

[Michael Carroll, Analyst at RBC Capital Markets]

Okay, great. Thanks. I appreciate it.

[Drew Babin, CFO at National Healthcare Properties Inc]

Thanks, Mike.

[Operator]

Your next question comes from the line of Austin Wurschmidt with KeyBanc Capital Markets. Your line is open. Please go ahead.

[Austin Wurschmidt, Analyst at KeyBanc Capital Markets]

Yeah, thank you. Just sticking with the SHOP theme here. Last quarter you talked about the spot occupancy north of 85% at quarter end. Clearly, there were some impacts to the portfolio as well as some industry factors, maybe, that have led to less sequential improvement in occupancy than might've been anticipated. If you break out the six assets, is there a significant NOI growth differential between the remainder of the pool and those six assets specifically?

[Drew Babin, CFO at National Healthcare Properties Inc]

Yeah, I think the main reason why you saw the disruption in occupancy, if you look back, I don't think we disclosed the same store. If you look back in our past supplementals, we break out occupancy by that type. The sequential increases we had in occupancy between 1Q and 2Q last year were, call it 300 basis points, 350 basis points for AL and Memory Care. Obviously, it's hard to kind of repeat that type of sequential gain. What we did see is better RevPOR growth. To Michael's point earlier, with street rates, we'll see that pick up, which is obviously what you want to see when occupancy is higher. We're seeing margins continue to improve.

[Drew Babin, CFO at National Healthcare Properties Inc]

I think, again, I think the occupancy piece is just one piece of the puzzle and one that has lagged a little bit seasonally versus what we normally see. Very little change in our forecast as far as where we think things are going to end up into the fourth quarter. Just a slight lag in getting there on the occupancy side.

[Austin Wurschmidt, Analyst at KeyBanc Capital Markets]

Yeah. That's helpful. I know kind of concessions played in. I think some burned off maybe from the first quarter, the second quarter, which may have helped drive that acceleration. How do we think about the year-over-year RevPOR growth now into the third quarter, given the usage of concessions and that presumably kind of helping lift occupancy towards the back half of the year, as you've talked about?

[Drew Babin, CFO at National Healthcare Properties Inc]

Yeah. I think there'll be a tension between better rate growth that we're seeing on higher occupied properties with better street rates and the concessions that I mentioned at some properties. It's TBD kind of which will win out. If we see a little bit of deceleration in RevPOR, in the interest of gaining occupancy at some of these lower occupancy properties, again, we think that's the right thing to do to maximize NOI.

[Austin Wurschmidt, Analyst at KeyBanc Capital Markets]

Just last one. Is the usage of concessions or is there competing product within this market, or has it just been a little bit slower to see the occupancy improvement that some of the broader industry has? What's sort of the biggest driver for using concessions given what's otherwise a pretty good fundamental backdrop? Thanks.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah. It's not really a competing product issue. I think it's mostly strategic personnel changes, and having turned rooms, wanting to fill those rooms. Our view is that in the long term, using a one-month concession to lock in a 24-month stay and increase margin, increase NOI is the right thing. Bringing some of those—it's a pretty limited number of properties that sit at sub 85% for us, and being able to bring those properties north of 85%, where we start to see that margin flow through, really enhance is kind of the strategy around that. I think that we'll see that play out, but we think ultimately that's the right play on that.

[Michael Anderson, CEO at National Healthcare Properties Inc]

As we mentioned, around nine or 10 of our communities, we've been seeing 3%-5% in place kind of dynamic changes, even above new rates that were reset in January. We're seeing where we have highly occupied properties, we're seeing a lot of pricing power in those markets, and ultimately that's the direction that we'd like to see the entire portfolio move.

[Austin Wurschmidt, Analyst at KeyBanc Capital Markets]

Helpful. Appreciate it, the added detail.

[Drew Babin, CFO at National Healthcare Properties Inc]

Thank you.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thanks.

[Operator]

Your next question comes from the line of Rob Stevenson with Huntington. Your line is open. Please go ahead.

[Rob Stevenson, Analyst at Huntington]

Good afternoon, guys. Just one from me. How much CapEx are you expecting to put into the $400 million of second and third quarter announced and completed acquisitions at this point, given a preliminary run through?

[Drew Babin, CFO at National Healthcare Properties Inc]

Yeah. Hey, Rob. It's Drew. On the Discovery deal, we talked a bit before, where there's about $6 million or so of CapEx going into that one. On other properties, I think that in the aggregate, maybe a similar amount. I think we're not excited about buying things that need true deferred maintenance. I think most of what we're buying, we're most excited about revenue enhancing type opportunities that are there. I wouldn't say it's that material or that much kind of in excess of the $6 million we have on Discovery. Maybe in the aggregate it's another $5 million-$10 million.

[Rob Stevenson, Analyst at Huntington]

Okay. That's helpful. I guess when you're looking at the stuff that hasn't been specifically announced, as well as what's in the pipeline, what type of mix are you looking at there between the various buckets? I assume the vast majority of it's assisted, but is there more independent living in this stuff, or is it basically almost all Assisted Living and Memory Care?

[Drew Babin, CFO at National Healthcare Properties Inc]

Yeah. I think it's going to be pretty similar to what we currently own. We're not standalone IL buyers. It's not really where we focus. We also like to maintain a very high percentage of private pay beds, where our pipeline really looks a lot like our current portfolio. I think AL will continue to be kind of the main thread through our pipeline. To the extent we have IL, it's more of a feeder within the same properties, and Memory Care is a valuable business and an important business that mixes in as well. You shouldn't see too much of a change in the composition of our portfolio as we grow.

[Rob Stevenson, Analyst at Huntington]

Okay. Thanks, guys.

[Drew Babin, CFO at National Healthcare Properties Inc]

Thank you.

[Operator]

Your next question comes from the line of Wesley Golladay with Baird. Your line is open. Please go ahead.

[Wesley Golladay, Analyst at Baird]

Hey, good afternoon, everyone. Just a quick question on the back half of the year on the compensation front. How does it look versus what you originally planned for the year with all these changes you made?

[Drew Babin, CFO at National Healthcare Properties Inc]

We upped the stock comp portion of it a bit. Obviously adding Al to the board. There's some shares there. Anytime a director exits, as we had that situation earlier this year. There can be accelerated vesting, and there's been some impact there. As Michael mentioned earlier, we're continuing on recruiting additional board members. To the extent we have new board members joining throughout the year, there could be additional grants. Really that's kind of the only adjustment there. I'll make one more comment, that total G&A guidance does not really contemplate any changes as a result of kind of remixing our business. To the extent directionally we move out of the OMF segment, there could be some potential savings there. We feel better quantifying that once some of these transactions have closed.

[Drew Babin, CFO at National Healthcare Properties Inc]

As our portfolio reconstitution kind of further materializes, we'll update it as the year goes on.

[Wesley Golladay, Analyst at Baird]

No, I appreciate all that. I was actually looking for on the SHOP side, being that you made some changes on the staffing there versus your expectations, I do appreciate the G&A answer as well. That was helpful.

[Drew Babin, CFO at National Healthcare Properties Inc]

For sure. Yeah. We already contemplated the additions to the SHOP team in guidance last quarter. There's really no change related to that.

[Wesley Golladay, Analyst at Baird]

Okay. Thank you very much.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Yeah, I'd say no meaningful changes in terms of SHOP comp expense as a result of some of the strategic changes that we made in the second quarter at those communities.

[Wesley Golladay, Analyst at Baird]

Okay. Thank you.

[Drew Babin, CFO at National Healthcare Properties Inc]

Thanks, Wesley.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thanks.

[Operator]

We've reached the end of the Q&A session. I will now turn the call back to Michael Anderson for closing remarks.

[Michael Anderson, CEO at National Healthcare Properties Inc]

Thank you. Thank you all for joining us this afternoon. We're excited about the results from this quarter, excited about the direction that we see the second half of the year continuing towards, and we really look forward to sharing additional updates as we have them over the course of the year and appreciate the time this afternoon. Thanks.

[Operator]

This concludes today's call. Thank you for attending. You may now disconnect.

Participants

Executives

• Michael Ozuna, Director of Investor Relations
• Michael Anderson, CEO
• Drew Babin, CFO

Analysts

• John Kilichowski, Analyst at Wells Fargo
• Ronald Kamdem, Analyst at Morgan Stanley
• Julien Blouin, Analyst at Goldman Sachs
• Robin Haneland, Analyst at BMO Capital Markets
• Michael Carroll, Analyst at RBC Capital Markets
• Austin Wurschmidt, Analyst at KeyBanc Capital Markets
• Rob Stevenson, Analyst at Huntington
• Wesley Golladay, Analyst at Baird